Breaking News

Proper Sun Protection...It's THAT Worth It!

April 8, 2014

L'Oréal promotes sunscreen use and melanoma research.

L'Oreal Paris and the Melanoma Research Alliance (MRA), a private funder of melanoma research, have launced It's THAT Worth It, a public health campaign that urges women of all skin tones to prevent melanoma by using sunscreen and to help save lives by supporting cutting-edge melanoma research for a cure. As part of the three-year partnership, L'Oreal Paris is donating $750,000 to MRA to help find a cure through the funding of the new L'Oreal Paris-MRA Team Science Award, led by cancer researcher Meenhard Herlyn, D.V.M., D.Sc., The Wistar Institute, Philadelphia, PA. The donation will fund research exploring the role of 16 variant genes as co-drivers in melanoma susceptibility, development and progression.

"The Melanoma Research Alliance is an incredible organization that has made significant strides in funding melanoma research and advancing treatment. We are very proud to partner with MRA to help educate people on the importance of using sunscreen as the first line of defense against melanoma and to drive awareness around this disease," said Karen T. Fondu, president, L'Oreal Paris. "Through this collaboration, our hope is to drastically reduce the growing incidence of melanoma in this country, especially among young women, and to help every person realize that wearing sunscreen protects their beauty and their life because we are all worth it."

Melanoma is the deadliest form of skin cancer and one of the most common cancers in women under 40.[1] L'Oréal and MRA are teaming up as the incidence of melanoma continues to soar. According to L'Oréal:

• Melanoma of the skin is the deadliest form of skin cancer, responsible for 80% of skin cancer deaths.[2]
• Melanoma is the fifth most common cancer diagnosed in the U.S.[3]
• The incidence of melanoma has tripled in the last 30 years, making it one of the fastest growing cancers.[4]
• Melanoma is the third most commonly diagnosed cancer among adolescents and young adults aged 15-39 in the US.[5]
• Very early stage (localized Stage 0 or 1) melanoma is greater than 90% curable with surgery, while patients with disseminated
• Stage IV melanoma have a median life expectancy of less than one year.[6]

To promote the campaign, celebrity broadcast and print PSAs are the first phase in a series of initiatives designed to rally the public. The PSAs drive the public to to join Thunderclap, a worldwide crowd sourcing tool that amplifies a collective message. By signing up for the It's THAT Worth It Thunderclap from now through May 20th at 5:00PM EDT, people can lend their reach to the cause, and send a synchronized message through social media, telling the world that they are committed to stopping melanoma through prevention and research.  As a thank you, L'Oreal Paris will make a donation to MRA of $1 for each supporter who signs up for the Thunderclap and $1 for each L'Oreal Paris Advanced Suncare product sold in the U.S. -- up to $250,000 in 2014. The May 20 Thunderclap event will include Celebrity Spokespeople Eva Longoria, Aimee Mullins, Lea Michele, Skin Cancer Survivor Diane Keaton and L'Oreal Paris Executive Danielle Macaluso.

"L'Oreal Paris' commitment to supporting groundbreaking research and rallying the public to stop melanoma from taking more lives is both incredibly inspiring and unprecedented," said Debra Black, MRA founder and melanoma survivor.

MRA is a public charity formed in 2007 under the auspices of the Milken Institute, with the generous founding support of Debra and Leon Black. MRA has dedicated more than $51 million to research seeking to better prevent, diagnose, and treat melanoma, the most deadly type of skin cancer.  Due to the ongoing support of its founders, 100% of every dollar MRA raises goes to support its melanoma research program. The organization is poised to build on recent momentum in the field, accelerating the pace of scientific discovery and translation in order to eliminate suffering and death due to melanoma.  MRA's ability to fund wide-ranging research in melanoma is amplified by unique multi-faceted collaborations and partnerships with individuals, private foundations and corporations.

For more information, visit

[1] American Cancer Society. Cancer Facts & Figures 2013. Accessed January 31, 2013.
[2] Melanoma Research Alliance.
[3] SEER Statistics,
[4] Edwards et al, Cancer, 2010.
[5] Weir et al. Melanoma in Adolescents and Young Adults: United States, 1999-2006, 2011
[6] Melanoma Research Alliance.


Related End-User Markets:

blog comments powered by Disqus
  • Let the Magic Begin!

    Let the Magic Begin!

    Tom Branna, Editorial Director||October 10, 2016
    IFSCC Congress gets underway at Walt Disney World this month.

  • Ogee Opens for Business

    Ogee Opens for Business

    Christine Esposito, Associate Editor||October 10, 2016
    Banking on the power of jojoba oil, a Vermont-based start-up is the newest player in organic luxury skin care.

  • P&G’s Latest Patents

    P&G’s Latest Patents

    Christine Esposito, Associate Editor||October 10, 2016
    A look at recent patent and IP related news from the biggest household and personal care player in the US.

  • Skin Care of One’s Own

    Skin Care of One’s Own

    Christine Esposito, Associate Editor||October 3, 2016
    Nu Skin’s ageLOC Me—which melds the worlds of smart-phone technology, efficacious ingredients and personalization

  • Proof Positive

    Proof Positive

    Christine Esposito, Associate Editor||October 3, 2016
    Testing service providers enable companies to back up their claims and stay in compliance with regulations.

  • Change Is in the Air

    Change Is in the Air

    Doreen Wang, BrandZ ||October 3, 2016
    Technology is changing the personal care market